Annual CFI
-$160.00 K
+$599.00 K+78.92%
01 December 2023
Summary:
Plus Therapeutics annual cash flow from investing activities is currently -$160.00 thousand, with the most recent change of +$599.00 thousand (+78.92%) on 01 December 2023. During the last 3 years, it has risen by +$333.00 thousand (+67.55%). PSTV annual CFI is now -100.93% below its all-time high of $17.27 million, reached on 31 December 2002.PSTV Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$9000.00
+$3.79 M+99.76%
01 September 2024
Summary:
Plus Therapeutics quarterly cash flow from investing activities is currently -$9000.00, with the most recent change of +$3.79 million (+99.76%) on 01 September 2024. Over the past year, it has increased by +$33.00 thousand (+78.57%). PSTV quarterly CFI is now -100.15% below its all-time high of $6.03 million, reached on 31 December 2002.PSTV Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$4.22 M
+$1000.00+0.02%
01 September 2024
Summary:
Plus Therapeutics TTM cash flow from investing activities is currently -$4.22 million, with the most recent change of +$1000.00 (+0.02%) on 01 September 2024. Over the past year, it has dropped by -$4.06 million (-2535.62%). PSTV TTM CFI is now -124.43% below its all-time high of $17.27 million, reached on 31 December 2002.PSTV TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +78.6% | -2535.6% |
| 3 y3 years | +67.5% | -125.0% | -2912.1% |
| 5 y5 years | -20.3% | -350.0% | -175.0% |
PSTV Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -95.1% | +78.9% | -550.0% | +99.8% | -5042.7% | +0.0% |
| 5 y | 5 years | -102.9% | +78.9% | -325.0% | +99.8% | -175.0% | +0.0% |
| alltime | all time | -100.9% | +99.6% | -100.2% | +99.8% | -124.4% | +33.6% |
Plus Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9000.00(-99.8%) | -$4.22 M(-0.0%) |
| June 2024 | - | -$3.80 M(+944.5%) | -$4.22 M(+887.8%) |
| Mar 2024 | - | -$364.00 K(+766.7%) | -$427.00 K(+166.9%) |
| Dec 2023 | -$160.00 K(-78.9%) | -$42.00 K(+320.0%) | -$160.00 K(+24.0%) |
| Sept 2023 | - | -$10.00 K(-9.1%) | -$129.00 K(-15.1%) |
| June 2023 | - | -$11.00 K(-88.7%) | -$152.00 K(-45.5%) |
| Mar 2023 | - | -$97.00 K(+781.8%) | -$279.00 K(-63.2%) |
| Dec 2022 | -$759.00 K(+825.6%) | -$11.00 K(-66.7%) | -$759.00 K(+1.7%) |
| Sept 2022 | - | -$33.00 K(-76.1%) | -$746.00 K(+4.0%) |
| June 2022 | - | -$138.00 K(-76.1%) | -$717.00 K(+24.7%) |
| Mar 2022 | - | -$577.00 K(<-9900.0%) | -$575.00 K(+601.2%) |
| Dec 2021 | -$82.00 K(-83.4%) | $2000.00(-150.0%) | -$82.00 K(-41.4%) |
| Sept 2021 | - | -$4000.00(-200.0%) | -$140.00 K(-6.7%) |
| June 2021 | - | $4000.00(-104.8%) | -$150.00 K(-73.5%) |
| Mar 2021 | - | -$84.00 K(+50.0%) | -$566.00 K(+14.8%) |
| Dec 2020 | -$493.00 K(-108.9%) | -$56.00 K(+300.0%) | -$493.00 K(-0.6%) |
| Sept 2020 | - | -$14.00 K(-96.6%) | -$496.00 K(+2.5%) |
| June 2020 | - | -$412.00 K(+3645.5%) | -$484.00 K(-108.7%) |
| Mar 2020 | - | -$11.00 K(-81.4%) | $5.57 M(-0.1%) |
| Dec 2019 | $5.57 M(-4288.0%) | -$59.00 K(+2850.0%) | $5.57 M(-1.0%) |
| Sept 2019 | - | -$2000.00(-100.0%) | $5.62 M(+0.9%) |
| June 2019 | - | $5.64 M(<-9900.0%) | $5.58 M(-6583.7%) |
| Mar 2019 | - | -$6000.00(+20.0%) | -$86.00 K(-35.3%) |
| Dec 2018 | -$133.00 K(-90.4%) | -$5000.00(-90.0%) | -$133.00 K(+171.4%) |
| Sept 2018 | - | -$50.00 K(+100.0%) | -$49.00 K(-70.3%) |
| June 2018 | - | -$25.00 K(-52.8%) | -$165.00 K(-39.6%) |
| Mar 2018 | - | -$53.00 K(-167.1%) | -$273.00 K(-80.3%) |
| Dec 2017 | -$1.38 M(-2260.9%) | $79.00 K(-147.6%) | -$1.38 M(+7.4%) |
| Sept 2017 | - | -$166.00 K(+24.8%) | -$1.29 M(+14.3%) |
| June 2017 | - | -$133.00 K(-88.6%) | -$1.13 M(+9.4%) |
| Mar 2017 | - | -$1.16 M(-768.4%) | -$1.03 M(-1709.4%) |
| Dec 2016 | $64.00 K(-110.4%) | $174.00 K(-3580.0%) | $64.00 K(-138.6%) |
| Sept 2016 | - | -$5000.00(-86.1%) | -$166.00 K(-20.2%) |
| June 2016 | - | -$36.00 K(-47.8%) | -$208.00 K(-58.0%) |
| Mar 2016 | - | -$69.00 K(+23.2%) | -$495.00 K(-19.2%) |
| Dec 2015 | -$613.00 K(-54.4%) | -$56.00 K(+19.1%) | -$613.00 K(+35.3%) |
| Sept 2015 | - | -$47.00 K(-85.4%) | -$453.00 K(-38.0%) |
| June 2015 | - | -$323.00 K(+72.7%) | -$731.00 K(-17.7%) |
| Mar 2015 | - | -$187.00 K(-279.8%) | -$888.00 K(-33.9%) |
| Dec 2014 | -$1.34 M(-136.4%) | $104.00 K(-132.0%) | -$1.34 M(-17.6%) |
| Sept 2014 | - | -$325.00 K(-32.3%) | -$1.63 M(-148.1%) |
| June 2014 | - | -$480.00 K(-25.2%) | $3.39 M(+2.0%) |
| Mar 2014 | - | -$642.00 K(+250.8%) | $3.33 M(-9.8%) |
| Dec 2013 | $3.69 M(-406.1%) | -$183.00 K(-103.9%) | $3.69 M(-1.5%) |
| Sept 2013 | - | $4.70 M(-960.1%) | $3.74 M(-426.8%) |
| June 2013 | - | -$546.00 K(+94.3%) | -$1.15 M(-21.6%) |
| Mar 2013 | - | -$281.00 K(+121.3%) | -$1.46 M(+21.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | -$1.20 M(+115.0%) | -$127.00 K(-33.5%) | -$1.20 M(+2.1%) |
| Sept 2012 | - | -$191.00 K(-77.8%) | -$1.18 M(+16.4%) |
| June 2012 | - | -$861.00 K(+3344.0%) | -$1.01 M(+123.1%) |
| Mar 2012 | - | -$25.00 K(-75.5%) | -$454.00 K(-18.9%) |
| Dec 2011 | -$560.00 K(-56.6%) | -$102.00 K(+308.0%) | -$560.00 K(-5.9%) |
| Sept 2011 | - | -$25.00 K(-91.7%) | -$595.00 K(-43.1%) |
| June 2011 | - | -$302.00 K(+130.5%) | -$1.04 M(-15.0%) |
| Mar 2011 | - | -$131.00 K(-4.4%) | -$1.23 M(-4.7%) |
| Dec 2010 | -$1.29 M(+483.7%) | -$137.00 K(-71.2%) | -$1.29 M(+1.3%) |
| Sept 2010 | - | -$475.00 K(-2.5%) | -$1.27 M(+44.6%) |
| June 2010 | - | -$487.00 K(+155.0%) | -$881.00 K(+118.6%) |
| Mar 2010 | - | -$191.00 K(+57.9%) | -$403.00 K(+82.4%) |
| Dec 2009 | -$221.00 K(-43.8%) | -$121.00 K(+47.6%) | -$221.00 K(+53.5%) |
| Sept 2009 | - | -$82.00 K(+811.1%) | -$144.00 K(+25.2%) |
| June 2009 | - | -$9000.00(0.0%) | -$115.00 K(-49.3%) |
| Mar 2009 | - | -$9000.00(-79.5%) | -$227.00 K(-42.2%) |
| Dec 2008 | -$393.00 K(-106.6%) | -$44.00 K(-17.0%) | -$393.00 K(-279.5%) |
| Sept 2008 | - | -$53.00 K(-56.2%) | $219.00 K(-92.2%) |
| June 2008 | - | -$121.00 K(-30.9%) | $2.81 M(-40.6%) |
| Mar 2008 | - | -$175.00 K(-130.8%) | $4.72 M(-21.0%) |
| Dec 2007 | $5.98 M(+912.2%) | $568.00 K(-77.6%) | $5.98 M(+11.1%) |
| Sept 2007 | - | $2.53 M(+41.1%) | $5.38 M(+17.3%) |
| June 2007 | - | $1.80 M(+65.7%) | $4.59 M(-21.6%) |
| Mar 2007 | - | $1.08 M(-3596.8%) | $5.85 M(+890.4%) |
| Dec 2006 | $591.00 K(-35.1%) | -$31.00 K(-101.8%) | $591.00 K(-182.2%) |
| Sept 2006 | - | $1.74 M(-43.1%) | -$719.00 K(-148.2%) |
| June 2006 | - | $3.06 M(-173.2%) | $1.49 M(-123.5%) |
| Mar 2006 | - | -$4.18 M(+211.6%) | -$6.35 M(-796.9%) |
| Dec 2005 | $911.00 K(-93.2%) | -$1.34 M(-133.9%) | $911.00 K(-83.5%) |
| Sept 2005 | - | $3.95 M(-182.6%) | $5.53 M(+15.4%) |
| June 2005 | - | -$4.78 M(-255.1%) | $4.79 M(-60.6%) |
| Mar 2005 | - | $3.08 M(-5.9%) | $12.15 M(-9.5%) |
| Dec 2004 | $13.43 M(+125.5%) | $3.28 M(+1.9%) | $13.43 M(+7.3%) |
| Sept 2004 | - | $3.21 M(+24.8%) | $12.51 M(+18.7%) |
| June 2004 | - | $2.58 M(-40.9%) | $10.54 M(+19.8%) |
| Mar 2004 | - | $4.36 M(+84.3%) | $8.80 M(+47.8%) |
| Dec 2003 | $5.95 M(-65.5%) | $2.36 M(+90.3%) | $5.95 M(-38.1%) |
| Sept 2003 | - | $1.24 M(+48.7%) | $9.62 M(-14.9%) |
| June 2003 | - | $835.00 K(-44.8%) | $11.30 M(-26.1%) |
| Mar 2003 | - | $1.51 M(-74.9%) | $15.29 M(-11.5%) |
| Dec 2002 | $17.27 M(+662.9%) | $6.03 M(+106.1%) | $17.27 M(+53.6%) |
| Sept 2002 | - | $2.92 M(-39.3%) | $11.24 M(+35.2%) |
| June 2002 | - | $4.82 M(+38.1%) | $8.31 M(+138.1%) |
| Mar 2002 | - | $3.49 M | $3.49 M |
| Dec 2001 | $2.26 M(-105.7%) | - | - |
| Dec 2000 | -$39.45 M(>+9900.0%) | - | - |
| Dec 1999 | -$381.00 K(-36.3%) | - | - |
| Dec 1998 | -$598.00 K | - | - |
FAQ
- What is Plus Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Plus Therapeutics?
- What is Plus Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Plus Therapeutics?
- What is Plus Therapeutics quarterly CFI year-on-year change?
- What is Plus Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Plus Therapeutics?
- What is Plus Therapeutics TTM CFI year-on-year change?
What is Plus Therapeutics annual cash flow from investing activities?
The current annual CFI of PSTV is -$160.00 K
What is the all time high annual CFI for Plus Therapeutics?
Plus Therapeutics all-time high annual cash flow from investing activities is $17.27 M
What is Plus Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of PSTV is -$9000.00
What is the all time high quarterly CFI for Plus Therapeutics?
Plus Therapeutics all-time high quarterly cash flow from investing activities is $6.03 M
What is Plus Therapeutics quarterly CFI year-on-year change?
Over the past year, PSTV quarterly cash flow from investing activities has changed by +$33.00 K (+78.57%)
What is Plus Therapeutics TTM cash flow from investing activities?
The current TTM CFI of PSTV is -$4.22 M
What is the all time high TTM CFI for Plus Therapeutics?
Plus Therapeutics all-time high TTM cash flow from investing activities is $17.27 M
What is Plus Therapeutics TTM CFI year-on-year change?
Over the past year, PSTV TTM cash flow from investing activities has changed by -$4.06 M (-2535.62%)